Health Care Equipment & Supplies · NYSE
BDXBecton Dickinson & Co
- Last close
- $218.03 +1.1%
- 52-week range
- $140.11 to $219.78
- Market cap
- $59.4B
- Next earnings
- Not scheduled
Fiscal 2025 at a glance
Stock price
Valuation vs its own 10 years
Below its 10-year median on 2 of 3 multiples
Where each multiple sits today inside its own range since 2016, measured at every quarter end. The thin tick is the median.
Key statistics
Trailing 12 months unless noted, through the quarter ending 2026-06-30. Every figure carries its unit.
Valuation
- P/E
- 65.9x
- Earnings yield
- 1.5%
- Price / sales
- 2.6x
- Price / book
- 2.4x
- Price / operating cash flow
- n/a
- EV / EBITDA
- 15.2x
- EV / sales
- 3.2x
- Free cash flow yield
- n/a
n/a: Not reported
Profitability
- Gross margin
- 46.9%
- Operating margin
- 10.7%
- Net margin
- 4.0%
- Return on equity
- 3.9%
- Return on capital
- 5.3%
Growth per year
- Revenue, 3 years
- +5.0%
- Revenue, 5 years
- +6.3%
- Revenue, 9 years
- +6.4%
- EPS, 3 years
- -0.3%
Balance sheet
- Cash and investments
- $708M
- Total debt
- $16.8B
- Net cash
- -$16.1B
- Debt / equity
- 0.69x
- Current ratio
- 0.87x
Shares and dividend
- Shares outstanding
- 272M
- Share count, 5 years
- +2.2%
- Beta, 1 year
- 0.29
- Dividend yield
- 1.9%
- Dividend per share, TTM
- $4.19
- Payout ratio
- 125%
Ten years of the business
Last 40 quarters, fiscal 2016 to 2025 and after. Hover a bar for its quarter.
Fiscal years 2016 to 2025.
Where the revenue comes from
Asia went from 16% to 14% of revenue in 3 years
Share of revenue by region, fiscal 2022 to 2025, as reported in the 10-K.
| Region | Revenue | Share | vs FY24 |
|---|---|---|---|
| US | $12.8B | 58.6% | +10% |
| EMEA | $4.73B | 21.7% | +7% |
| Asia | $3.09B | 14.2% | +6% |
| Others Country | $1.23B | 5.6% | +2% |
Health Care Equipment & Supplies peers
The largest names in the same industry that we cover, all in US dollars. The last column applies the same history test to each peer.
| Company | Market cap | Revenue growth | Operating margin | P/E | P/S | P/E vs own history |
|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | $188B | +10% | 13.8% | 40.4x | 3.9x | 60th percentile |
| DHR Danaher Corp | $164B | +6% | 20.4% | 38.1x | 6.4x | 65th percentile |
| ISRG Intuitive Surgical Inc | $154B | +20% | 28.4% | 53.7x | 13.3x | 48th percentile |
| MDT Medtronic plc | $132B | +10% | 18.1% | 25.3x | 3.5x | 20th percentile |
| SYK Stryker Corp | $118B | +8% | 20.7% | 33.0x | 4.5x | 30th percentile |
| BDX Becton Dickinson & Co | $59.4B | +17% | 10.7% | 65.9x | 2.6x | 74th percentile |
The company
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Founded
- 1897
- Headquarters
- Franklin Lakes, NJ
- Fiscal year ends
- September
- Website
- bd.com
What it does
Becton, Dickinson and Company is an American multinational medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD also provides consulting and analytics services in certain areas.
Description from Wikipedia (CC BY-SA).
Around the numbers
What the rest of EdgeStacker knows about BDX.